Logo image of YSG

YATSEN HOLDING LTD-ADR (YSG) Stock Fundamental Analysis

NYSE:YSG - New York Stock Exchange, Inc. - US9851942089 - ADR - Currency: USD

3.88  +0.02 (+0.52%)

After market: 3.88 0 (0%)

Fundamental Rating

3

Taking everything into account, YSG scores 3 out of 10 in our fundamental rating. YSG was compared to 37 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for YSG as it has an excellent financial health rating, but there are worries on the profitability. YSG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

YSG had negative earnings in the past year.
YSG had negative earnings in each of the past 5 years.
In the past 5 years YSG reported 4 times negative operating cash flow.
YSG Yearly Net Income VS EBIT VS OCF VS FCFYSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -1B -2B -3B

1.2 Ratios

With a Return On Assets value of -19.30%, YSG is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
YSG has a worse Return On Equity (-23.15%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -19.3%
ROE -23.15%
ROIC N/A
ROA(3y)-16.68%
ROA(5y)-20.05%
ROE(3y)-20.86%
ROE(5y)-24.99%
ROIC(3y)N/A
ROIC(5y)N/A
YSG Yearly ROA, ROE, ROICYSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

The Gross Margin of YSG (74.37%) is better than 88.89% of its industry peers.
In the last couple of years the Gross Margin of YSG has grown nicely.
YSG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y3.01%
YSG Yearly Profit, Operating, Gross MarginsYSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

YSG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for YSG has been reduced compared to 1 year ago.
The number of shares outstanding for YSG has been reduced compared to 5 years ago.
There is no outstanding debt for YSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
YSG Yearly Shares OutstandingYSG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
YSG Yearly Total Debt VS Total AssetsYSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

YSG has an Altman-Z score of 0.69. This is a bad value and indicates that YSG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of YSG (0.69) is worse than 69.44% of its industry peers.
There is no outstanding debt for YSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACC7.54%
YSG Yearly LT Debt VS Equity VS FCFYSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 5.04 indicates that YSG has no problem at all paying its short term obligations.
YSG has a Current ratio of 5.04. This is amongst the best in the industry. YSG outperforms 91.67% of its industry peers.
YSG has a Quick Ratio of 4.41. This indicates that YSG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of YSG (4.41) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 5.04
Quick Ratio 4.41
YSG Yearly Current Assets VS Current LiabilitesYSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.61% over the past year.
The Revenue for YSG has decreased by -36.54% in the past year. This is quite bad
The Revenue has been growing slightly by 6.93% on average over the past years.
EPS 1Y (TTM)51.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-36.54%
Revenue growth 3Y6.93%
Revenue growth 5YN/A
Sales Q2Q%-9.03%

3.2 Future

YSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.27% yearly.
YSG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.95% yearly.
EPS Next Y68.58%
EPS Next 2Y25.32%
EPS Next 3Y28.6%
EPS Next 5Y32.27%
Revenue Next Year-10.54%
Revenue Next 2Y-4.29%
Revenue Next 3Y-1.07%
Revenue Next 5Y-1.95%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
YSG Yearly Revenue VS EstimatesYSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
YSG Yearly EPS VS EstimatesYSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for YSG. In the last year negative earnings were reported.
Also next year YSG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YSG Price Earnings VS Forward Price EarningsYSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YSG Per share dataYSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

YSG's earnings are expected to grow with 28.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.32%
EPS Next 3Y28.6%

More info and screens

0

5. Dividend

5.1 Amount

YSG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

YATSEN HOLDING LTD-ADR

NYSE:YSG (2/21/2025, 8:04:00 PM)

After market: 3.88 0 (0%)

3.88

+0.02 (+0.52%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)03-04 2025-03-04/amc
Inst Owners20.44%
Inst Owner Change-93.94%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap382.41M
Analysts76.67
Price Target5.33 (37.37%)
Short Float %4.61%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.81%
Min EPS beat(2)-40.41%
Max EPS beat(2)-5.2%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.46%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)11.21%
Revenue beat(4)2
Avg Revenue beat(4)2.02%
Min Revenue beat(4)-7.9%
Max Revenue beat(4)11.21%
Revenue beat(8)6
Avg Revenue beat(8)6.33%
Revenue beat(12)7
Avg Revenue beat(12)3.6%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.81
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 1
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.79
BVpS5.57
TBVpS3.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.3%
ROE -23.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.37%
FCFM N/A
ROA(3y)-16.68%
ROA(5y)-20.05%
ROE(3y)-20.86%
ROE(5y)-24.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y3.01%
F-ScoreN/A
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.04
Quick Ratio 4.41
Altman-Z 0.69
F-ScoreN/A
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)54.99%
Cap/Depr(5y)287.87%
Cap/Sales(3y)1.91%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y68.58%
EPS Next 2Y25.32%
EPS Next 3Y28.6%
EPS Next 5Y32.27%
Revenue 1Y (TTM)-36.54%
Revenue growth 3Y6.93%
Revenue growth 5YN/A
Sales Q2Q%-9.03%
Revenue Next Year-10.54%
Revenue Next 2Y-4.29%
Revenue Next 3Y-1.07%
Revenue Next 5Y-1.95%
EBIT growth 1Y-13.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.68%
EBIT Next 3Y52.19%
EBIT Next 5YN/A
FCF growth 1Y-296.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-178.88%
OCF growth 3YN/A
OCF growth 5YN/A